Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMIT trial of low INR versus guideline INR after bileaflet mechanical aortic valve replacement
NL-OMON56927Phase 3Recruiting
- Sponsor
- Population Health Research Institute
- Start
- Dec 2023
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in thromboembolism and Bleeding (2 arms), sponsored by Population Health Research Institute. Primary endpoint: Major bleeding. Started Dec 2023; status: recruiting.
02
Conditions
thromboembolismBleeding
Beyond the preview
Go deeper on NL-OMON56927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON56927.